Association Provides Seed Grants For Clinical Chemists

Clinical chemists relate the chemical composition of tissue and body fluids to different illnesses--a critical step in the diagnosis and treatment of diseases. For them, as for investigators in most other fields today, transforming an idea into reality requires extensive funding. Sylvia Daunert, an assistant research professor at the University of Kentucky, is conducting research involving time-resolved fluorescence, creating more selective and sensitive assays for biomolecules and other biolo

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Sylvia Daunert, an assistant research professor at the University of Kentucky, is conducting research involving time-resolved fluorescence, creating more selective and sensitive assays for biomolecules and other biological compounds by using complexes of certain elements, such as europium, with fluorescent compounds. These complexes will fluoresce longer than compounds in existing biological and clinical samples and will bind either with antibodies or with the biomolecule being studied. This causes the fluorescent properties of the compound to be delayed, hence the name "time-resolved fluorescence."

Daunert was one of two recipients of $5,000 grants awarded last year by the Van Slyke Society, the philanthropic branch of the 40-year-old American Association for Clinical Chemistry (AACC), based in Washington, D.C. Despite its name, AACC includes members from countries outside the United States; the association currently has more than 10,000 members worldwide.

Daunert says that without such funding, ideas such as hers would never come to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • James Weil

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo